NewslettersHepatic Cell NewsUncategorizedMelatonin Is a Potential Oncostatic Agent to Inhibit HepG2 Cell Proliferation through Multiple PathwaysBy Justin.choi - January 27, 20220151Researchers investigated melatonin’s antitumor molecular mechanisms to inhibit the proliferation of HepG2 cells.[Heliyon] 7992332 {7992332:BBBBBBBB} apa 50 1 171161 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article